{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:32:37Z","timestamp":1783744357502,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1124\/molpharm.121.000402","type":"journal-article","created":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T12:05:18Z","timestamp":1635595518000},"page":"33-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors"],"prefix":"10.1016","volume":"101","author":[{"given":"Stefan","family":"Bidula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izzuddin Bin","family":"Nadzirin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cominetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean A.","family":"Cullum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Searcey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Fountain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.121.000402_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bcp.2016.11.016","article-title":"Characterization of P2X4 receptor agonists and antagonists by calcium influx and radioligand binding studies","volume":"125","author":"Abdelrahman","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"Suppl 1","key":"10.1124\/molpharm.121.000402_bib2","first-page":"S1","article-title":"The concise guide to pharmacology 2017\/18: overview","volume":"174","author":"Alexander","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.121.000402_bib3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41598-017-00732-5","article-title":"Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120","volume":"7","author":"Allsopp","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/molpharm.121.000402_bib4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/mol.114.096222","article-title":"Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels","volume":"87","author":"Ase","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.121.000402_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fncel.2019.00121","article-title":"An allosteric inhibitory site conserved in the ectodomain of P2X receptor channels","volume":"13","author":"Ase","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/molpharm.121.000402_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000350119","article-title":"Investigation of the inhibitory effects of the benzodiazepine derivative, 5-BDBD on P2X4 purinergic receptors by two complementary methods","volume":"32","author":"Bal\u00e1zs","year":"2013","journal-title":"Cell Physiol Biochem"},{"key":"10.1124\/molpharm.121.000402_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1124\/mol.119.116715","article-title":"Mapping the site of action of human P2X7 receptor antagonists AZ11645373, Brilliant Blue G, KN-62, calmidazolium, and ZINC58368839 to the intersubunit allosteric pocket","volume":"96","author":"Bin Dayel","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.121.000402_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijms21145005","article-title":"Resolving the ionotropic P2X4 receptor mystery points towards a new therapeutic target for cardiovascular diseases","volume":"21","author":"Bragan\u00e7a","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1124\/molpharm.121.000402_bib9","unstructured":"Case DA, Ben-Shalom IY, Brozell SR, Cerutti DS, Cheatham TE, Cruzeiro VWD, Darden TA, Duke RE, Ghoreishi D, Gilson MK, et al. (2018) AMBER 2018, University of California, San Francisco."},{"key":"10.1124\/molpharm.121.000402_bib10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.121.000402_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2018.10.047","article-title":"Characterization of the antagonist actions of 5-BDBD at the rat P2X4 receptor","volume":"690","author":"Coddou","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1124\/molpharm.121.000402_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jmb.2008.11.010","article-title":"RosettaLigand docking with full ligand and receptor flexibility","volume":"385","author":"Davis","year":"2009","journal-title":"J Mol Biol"},{"key":"10.1124\/molpharm.121.000402_bib13","unstructured":"Fischer R, Kalthof B, Gruetzmann, R, Woltering E, Stelte-Ludwig B, Wuttke (2004). Benzofuro-1,4-diazepin-2-one derivatives. Patent CA2519987A1."},{"key":"10.1124\/molpharm.121.000402_bib14","doi-asserted-by":"crossref","first-page":"15044","DOI":"10.1074\/jbc.M600442200","article-title":"A C-terminal lysine that controls human P2X4 receptor desensitization","volume":"281","author":"Fountain","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.121.000402_bib15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bpj.2009.11.018","article-title":"Accounting for ligand conformational restriction in calculations of protein-ligand binding affinities","volume":"98","author":"Gao","year":"2010","journal-title":"Biophys J"},{"issue":"D1","key":"10.1124\/molpharm.121.000402_bib16","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkx1121","article-title":"The IUPHAR\/BPS guide to pharmacology in 2018: updates and expansion to encompass the new guide to immunopharmacology","volume":"46","author":"Harding","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/molpharm.121.000402_bib17","doi-asserted-by":"crossref","first-page":"9576","DOI":"10.1021\/jm300845v","article-title":"N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists","volume":"55","author":"Hernandez-Olmos","year":"2012","journal-title":"J Med Chem"},{"key":"10.1124\/molpharm.121.000402_bib18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bph.15299","article-title":"Update of P2X receptor properties and their pharmacology: IUPHAR review 30","volume":"178","author":"Illes","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.121.000402_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.7554\/eLife.22153","article-title":"Structural basis for subtype-specific inhibition of the P2X7 receptor","volume":"5","author":"Karasawa","year":"2016","journal-title":"eLife"},{"key":"10.1124\/molpharm.121.000402_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/ijms20205113","article-title":"ATP-evoked intracellular Ca2+ responses in M-CSF differentiated human monocyte-derived macrophage are mediated by P2X4 and P2Y11 receptor activation","volume":"20","author":"Layhadi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1124\/molpharm.121.000402_bib21","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4049\/jimmunol.1700965","article-title":"ATP evokes Ca2+ responses and CXCL5 secretion via P2X4 receptor activation in human monocyte-derived macrophages","volume":"200","author":"Layhadi","year":"2018","journal-title":"J Immunol"},{"key":"10.1124\/molpharm.121.000402_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-61779-465-0_10","article-title":"Rosetta ligand docking with flexible XML protocols","volume":"819","author":"Lemmon","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1124\/molpharm.121.000402_bib23","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1021\/acs.jctc.9b00953","article-title":"Split the charge difference in two! A rule of thumb for adding proper amounts of ions in MD simulations","volume":"16","author":"Machado","year":"2020","journal-title":"J Chem Theory Comput"},{"key":"10.1124\/molpharm.121.000402_bib24","doi-asserted-by":"crossref","first-page":"32461","DOI":"10.1038\/srep32461","article-title":"A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain","volume":"6","author":"Matsumura","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/molpharm.121.000402_bib25","doi-asserted-by":"crossref","first-page":"14503","DOI":"10.1073\/pnas.1101039108","article-title":"Fusion-activated Ca2+ entry via vesicular P2X4 receptors promotes fusion pore opening and exocytotic content release in pneumocytes","volume":"108","author":"Miklavc","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/molpharm.121.000402_bib26","doi-asserted-by":"crossref","first-page":"W622","DOI":"10.1093\/nar\/gkq325","article-title":"Frog2: efficient 3D conformation ensemble generator for small compounds","volume":"38","author":"Miteva","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/molpharm.121.000402_bib27","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/bph.14677","article-title":"Action of MK-7264 (gefapixant) at human P2X3 and P2X2\/3 receptors and in vivo efficacy in models of sensitisation","volume":"176","author":"Richards","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1124\/molpharm.121.000402_bib28","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J Chem Theory Comput"},{"key":"10.1124\/molpharm.121.000402_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J Mol Biol"},{"key":"10.1124\/molpharm.121.000402_bib30","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0028-3908(97)00138-X","article-title":"HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors","volume":"36","author":"Schachter","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1124\/molpharm.121.000402_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1183\/13993003.01615-2019","article-title":"Gefapixant in two randomised dose-escalation studies in chronic cough","volume":"55","author":"Smith","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1124\/molpharm.121.000402_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4939-9717-6_4","article-title":"Homology modeling of P2X receptors","volume":"2041","author":"Stavrou","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1124\/molpharm.121.000402_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fphar.2017.00291","article-title":"P2X4 receptor function in the nervous system and current breakthroughs in pharmacology","volume":"8","author":"Stokes","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1124\/molpharm.121.000402_bib34","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3389\/fimmu.2018.01531","article-title":"Purinergic cooperation between P2Y(2) and P2X7 receptors promote cutaneous Leishmaniasis control: involvement of pannexin-1 and leukotrienes","volume":"9","author":"Thorstenberg","year":"2018","journal-title":"Front Immunol"},{"key":"10.1124\/molpharm.121.000402_bib35","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nature01786","article-title":"P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury","volume":"424","author":"Tsuda","year":"2003","journal-title":"Nature"},{"key":"10.1124\/molpharm.121.000402_bib36","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1016\/j.bmc.2017.05.031","article-title":"Synthesis and preliminary biological evaluation of radiolabeled 5-BDBD analogs as new candidate PET radioligands for P2X4 receptor","volume":"25","author":"Wang","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/molpharm.121.000402_bib37","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1097\/j.pain.0000000000001587","article-title":"Antibodies binding the head domain of P2X4 inhibit channel function and reverse neuropathic pain","volume":"160","author":"Williams","year":"2019","journal-title":"Pain"},{"key":"10.1124\/molpharm.121.000402_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nm1338","article-title":"Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice","volume":"12","author":"Yamamoto","year":"2006","journal-title":"Nat Med"},{"key":"10.1124\/molpharm.121.000402_bib39","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/CIRCHEARTFAILURE.113.001023","article-title":"Novel protective role of endogenous cardiac myocyte P2X4 receptors in heart failure","volume":"7","author":"Yang","year":"2014","journal-title":"Circ Heart Fail"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24012148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24012148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.121.000402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:49:05Z","timestamp":1739954945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24012148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0026895X24012148"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.121.000402","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.121.000402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}